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We report a rare case presenting recurrent syncope in a 50-
year-old woman due to idiopathic glossopharyngeal
neuralgia (GN).
The patient presented at the emergency department for
recurrent syncope, starting 1 week before presentation. All
episodes of syncope started with a sharp stabbing pain
sensation in the left anterior side of the throat, distributing
to the ipsilateral side of the neck and ear, accompanied by
heavy swallowing, rotating of the head to the right, gener-
alized tonic seizure-like movements of both arms and legs
with the urge to grab the left side of the neck with her hands,
and eventually followed by syncope. Syncope lasted from a
few seconds up to a minute. After the attack, the patient
regained complete consciousness. No postictal symptoms,
such as urine incontinency or tongue bite, had occurred.
Furthermore, no cardiac symptoms, such as chest pain,
palpitations, or vasovagal symptoms, occurred before syn-
cope. Talking, turning of the head, emotional stress, palpi-
tation of the neck, or even sleeping could initiate a new
episode of syncope.
There was no history of trauma, unexplained syncope,
and epileptic insults or a family history of acute unexplained
death. In the year before the presentation, the patient had
suffered from recurrent pain on the left side of the neck
without syncope for several weeks in 2 different episodes.
Complete remission had occurred without any form of
medical intervention.
Physical examination revealed an anxious woman. Blood
pressure was 125/80 mm Hg with a regular pulse rate of 80
beats/min. The general and cardiologic examination was
considered normal. Direct ﬂexible laryngoscopy as well asKEYWORDS Glossopharyngeal neuralgia; Cardiac syncope
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no evidence of abnormality.
Neurological examination demonstrated trigger areas in
the distribution of the glossopharyngeal nerve; palpation of
the left side of the neck or performing the Weber and the
Rinne tests (hearing tests) resulted in neck pain with
subsequent bradycardia and asystole, during which patient
temporarily lost consciousness. Both noninvasive and inva-
sive monitoring showed a simultaneous decrease in the heart
rate and blood pressure with the onset of pain (Figure 1).
An additional investigation showed normal hematological
and biochemical examinations. An electrocardiogram dem-
onstrated a sinus rhythm of 83 beats/min, an intermediate
heart axis, and normal conduction intervals (PQ interval 150
ms, QRS interval 94 ms, and corrected QT interval 430 ms).
No signs of preexcitation, ischemia, or Brugada syndrome
were seen on the electrocardiogram. A computed tomo-
graphic scan and a magnetic resonance image of the brain,
neck, and heart showed no evidence of a tumor or malfor-
mation of the aorta, carotid artery, cervical vasculature, or the
circle of Willis. Furthermore, the parotid and the subman-
dibular gland and their relationship with brain nerves IX and
X were considered normal. An additional magnetic reso-
nance image addressing the anatomical relationship between
cranial nerves and vessels demonstrated neurovascular
compression of nerve IX by a thick posterior inferior
cerebellar artery (PICA). (Figures 2A and 2B).
The diagnosis of GN was made, and pregabalin 150 mg 3
times daily was initiated. Simultaneously, a temporary
transvenous pacemaker was inserted because of the increas-
ing frequency and length of syncopal episodes. This resulted
in a reduction of the length of syncope (Figure 3). Therefore,
a permanent demand dual-chamber pacemaker was
implanted and no further episodes of syncope occurred.
Although the frequency and intensity of the pain and the
length of syncope were reduced by both interventions, the patient
still experienced GN-related pain attacks and pregabalin was
replaced by carbamazepine 200 mg (up to 5 times daily).
Eventually, lamotrigine 200 mg 2 times daily was added
to the drug regimen. This regimen of carbamazepine andpen access article under the CC BY-NC-ND license
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KEY TEACHING POINTS
 Craniofacial pain and syncope are associated with
glossopharyngeal neuralgia (GN).
 Carbamazepine is considered a ﬁrst-line
treatment of GN.
 Bradyarrhythmic complications of GN are treated
with anticholinergic medications or with a β2-
adrenoreceptor agonist.
 The need for demand dual-chamber pacemakers in
the long-term treatment of GN remains
controversial.
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related pain, and surgery was canceled.GN
GN is a rare condition of craniofacial pain and represents
0.2%–1.3% of the cases with facial pain.1,2 The incidence of
GN is approximately 0.8 per 100,000 persons per year and
occurs more frequently in male subjects with a mean age of
50.2  14 years.1,3–8 The frequency of cardiac syncope in
GN is 2%–20%.5,9 The diagnostic criteria of GN according
to the International Headache Society are listed in Table 1.10
However, the frequency of GN is underestimated because of
difﬁculties in clinical diagnosis and unawareness of the
disease.11
The pain in GN is characterized by paroxysmal lancinat-
ing pain and is usually conﬁned to the unilateral somato-
sensory distribution of the glossopharyngeal or the auricular
and pharyngeal branches of the vagus, such as the pharynx. It
commonly radiates to the ear and subauricular area, as well
as the lateral aspect of the throat and submandibular
region.12,13 The pain lasts from a few seconds to 5 minutes
and is often precipitated or triggered by chewing, coughing,
yawning, talking, and swallowing.14 Although trigger zones
are rarely found in GN, syncope in our patient could be
provoked by palpitation of the neck and by speciﬁc neuro-
logical examination. Accompanying symptoms include stri-
dor, coughing, hoarseness, vomiting, sweating, and
hypersalivation. GN must be differentiated from trigeminal
neuralgia, which shares several characteristics with GN and
can occur in a combined form in 10% of patients.15 Like
trigeminal neuralgia, GN may go into spontaneous
remission.5
“Idiopathic” cranial nerve neuralgias are attributed to a
neurovascular nerve compression syndrome at the root entry
zone of the respective cranial nerve.11 GN is generally
caused by neurovascular compression of nerve IX by the
PICA,11 which was ﬁrst observed postmortem by
Brihaye et al.16 However, several other mechanisms, besides
intracranial vascular compression,16–21 may cause GN
and include Eagle syndrome,22 cerebellopontine angle or
cranial base tumors,23 Chiari type I syndrome,24 pharyngealtumors and abscesses,25–27 posterior fossa arteriovenous
malformations, trauma,28 and multiple sclerosis.29 In our
patient, these causes were excluded by neurovascular
imaging.
Neurological syncope cascade
Syncope in GN related to neuralgic pain is most likely
caused by activation of the dorsal motor nucleus of the
vagus nerve by abnormally enhanced input from afferent or
ischemic lesions of the glossopharyngeal nerve.30 The
reﬂex arrhythmia could be explained from the fact that
afferent nerve impulses from the glossopharyngeal nerve
may reach the tractus solitarius of the brainstem and via
collateral ﬁbers reach the dorsal motor nucleus of the vagus
nerve.31 One afferent branch of the glossopharyngeal nerve
supplies the somatosensorial information to the nucleus
ambiguus, while another afferent branch of the glossophar-
yngeal nerve, the carotid sinus nerve (Hering nerve),
conducts impulses from the body of the carotid sinus to
the nucleus dorsalis of the vagal nerve.32 It has been
hypothesized that by artiﬁcial synapses in the glossophar-
yngeal nerve the impulses from the somsatosensorial
branches stimulate the carotid sinus nerve and thereby the
nucleus dorsalis. Activation of this abnormal loop during
severe neuralgic pain would be responsible for bradycardia/
asystole, with cerebral hypoperfusion, slowing of electro-
encephalographic activity, syncope, and convulsions in
proportion to the duration of asystole.33 Individual differ-
ences in the susceptibility of the dorsal motor nucleus to the
pain impulse may explain why not all cases are associated
with syncope.
Treatment
Both medical and surgical treatments have been used to treat
GN.34
Carbamazepine is considered as a ﬁrst-line treatment and is
thought to be useful in controlling GN-related pain by the
inhibitory effect on the brain stem reﬂex activity.35 Further-
more, it possibly prevents bradycardia.36,37 Other medical
treatments have been reported and include gabapentin,
lamotrigine, and pregabalin.38–41 Both pregabalin and
gabapentin induce a decreasing release of excitatory neuro-
transmitters by acting on the α2δ subunit of calcium chan-
nels.41 Bradyarrhythmic complications of GN are treated with
anticholinergic medications or with a β2-adrenoceptor agonist,
such as atropine, isoprenaline, or with temporary pacing.
The need for on-demand dual-chamber pacemakers in the
long-term treatment of GN remains controversial.31,42 In
1971, a temporary transvenous cardiac pacemaker was
inserted for the ﬁrst time to prevent GN-related syncope.43
However, pacing might prevent or only reduces the length
of syncope and does not affect GN-related pain. Further-
more, pacing may not be effective in preventing GN-related
syncope in patients who have important vasodepressor
response.44–46 A permanent demand pacemaker, combined
with medical treatment, should be considered depending on
Figure 1 Continuous monitor lead electrocardiogram showing asystole followed by bradycardia and junctional escape during neuralgic pain.
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before addressing surgical intervention.44Neurovascular surgery
Microvascular decompression is a second-line treatment in
idiopathic GN and is reserved only for those who have
failed medical treatment and have dual-chamber pace-
makers.14,47 During this surgery, dissection of the vessel
will take place according to the trigeminal nerve decom-
pression suggested by Jannetta and coworkers,47 followedby placing a Teﬂon interpositum. The rationale behind
surgery is that GN is caused by direct compression of the
root entry zone of the glossopharyngeal nerve, most often
by the PICA, and vascular decompression could resolve
this.11 In 1977, Laha et al were the ﬁrst to report good
results of microvascular decompression for GN.18 Gaul
et al11 demonstrated that 16 of the 18 patients were
completely pain free after microsurgical decompression
for GN and no longer needed any anticonvulsant or other
pain medication. Furthermore, studies have shown excel-
lent long-term results.8,48
Figure 2 A:MRI axial 3D T2 SPACE: the arrow points to the posterior inferior cerebellar artery that cross the glossopharyngeal nerve closely. B:MRI axial
3D TOF: the hyperintense line next to the brainstem is the thick posterior inferior cerebellar artery. 3D¼ 3-dimensional; MRI¼magnetic resonance imaging; T2
SPACE = Sampling Perfection with Application optimized Contrasts using different ﬂip angle Evolution; TOF =Time of Flight.
Figure 3 Continuous monitor lead electrocardiogram showing the effect of the pacemaker during an attack.
Table 1 Diagnostic criteria of glossopharyngeal neuralgia according to the International Headache Society10
1. At least 3 attacks of unilateral pain fulﬁlling criteria 2 and 3.
2. Pain is located in the posterior part of the tongue, tonsillar fossa, pharynx, or beneath the angle of the lower jaw and/or in the ear.
3. Pain has at least 3 of the following 4 characteristics:
a. Recurring in paroxysmal attacks lasting from a few seconds to 2 min
b. Severe intensity
c. Shooting, stabbing, or sharp in quality
d. Precipitated by swallowing, coughing, talking, or yawning
4. No clinically evident neurological deﬁcit
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